Article
Licensed
Unlicensed
Requires Authentication
CHIRALITY AND PHARMACOKINETICS: AN AREA OF NEGLECTED DIMENSIONALITY?
-
Andrew J. Hutt,
Published/Copyright:
June 1, 2007
Published Online: 2007-06
©2011 by Walter de Gruyter GmbH & Co.
You are currently not able to access this content.
You are currently not able to access this content.
Articles in the same Issue
- CONTENTS
- CHIRALITY AND PHARMACOKINETICS: AN AREA OF NEGLECTED DIMENSIONALITY?
- A REVIEW ON THE RELATION BETWEEN THE BRAIN-SERUM CONCENTRATION RATIO OF DRUGS AND THE INFLUENCE OF P-GLYCOPROTEIN
- EVALUATION OF THE CHEMOPROTECTIVE EFFECT OF Biophytum sensitivum (L.) DC EXTRACT AGAINST CYCLOPHOSPHAMIDE INDUCED TOXICITY IN SWISS ALBINO MICE
- EFFECT OF RIFAMPICIN PRETREATMENT ON THE TRANSPORT ACROSS RAT INTESTINE AND ORAL PHARMACOKINETICS OF ORNIDAZOLE IN HEALTHY HUMAN VOLUNTEERS
- BIOAVAILABILITY OF DICLOFENAC SODIUM AFTER PRETREATMENT WITH DIOSMIN IN HEALTHY VOLUNTEERS
- EFFECT OF SILYMARIN ON THE ORAL BIOAVAILABILITY OF RANITIDINE IN HEALTHY HUMAN VOLUNTEERS
- ISOFLURANE REDUCES THE SYNTHESIS OF SURFACTANT-RELATED PROTEIN A OF ALVEOLAR TYPE II CELLS INJURED BY H2O2
- RHABDOMYOLYSIS AFTER ADDITION OF DIGITOXIN TO CHRONIC SIMVASTATIN AND AMIODARONE THERAPY
Articles in the same Issue
- CONTENTS
- CHIRALITY AND PHARMACOKINETICS: AN AREA OF NEGLECTED DIMENSIONALITY?
- A REVIEW ON THE RELATION BETWEEN THE BRAIN-SERUM CONCENTRATION RATIO OF DRUGS AND THE INFLUENCE OF P-GLYCOPROTEIN
- EVALUATION OF THE CHEMOPROTECTIVE EFFECT OF Biophytum sensitivum (L.) DC EXTRACT AGAINST CYCLOPHOSPHAMIDE INDUCED TOXICITY IN SWISS ALBINO MICE
- EFFECT OF RIFAMPICIN PRETREATMENT ON THE TRANSPORT ACROSS RAT INTESTINE AND ORAL PHARMACOKINETICS OF ORNIDAZOLE IN HEALTHY HUMAN VOLUNTEERS
- BIOAVAILABILITY OF DICLOFENAC SODIUM AFTER PRETREATMENT WITH DIOSMIN IN HEALTHY VOLUNTEERS
- EFFECT OF SILYMARIN ON THE ORAL BIOAVAILABILITY OF RANITIDINE IN HEALTHY HUMAN VOLUNTEERS
- ISOFLURANE REDUCES THE SYNTHESIS OF SURFACTANT-RELATED PROTEIN A OF ALVEOLAR TYPE II CELLS INJURED BY H2O2
- RHABDOMYOLYSIS AFTER ADDITION OF DIGITOXIN TO CHRONIC SIMVASTATIN AND AMIODARONE THERAPY
